Cite
HARVARD Citation
Lamarca, A. et al. (2021). Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet oncology. 22 (5), pp. 690-701. [Online].